US Broker Ratings

Treace Medical Concepts, Inc. (TMCI) Investor Outlook: Exploring a Potential 121% Upside

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a pioneering entity in the healthcare sector, is drawing investor attention with its innovative approach to medical devices, particularly in..

EyePoint, Inc. (EYPT) Stock Analysis: A Biotech Gem with 177% Potential Upside

EyePoint, Inc. (EYPT), a prominent player in the biotechnology sector, is making waves with its innovative approach to treating serious retinal diseases. With a market capitalization..

Auna SA (AUNA) Stock Analysis: Exploring a 43% Potential Upside in the Healthcare Sector

Auna SA (AUNA), a key player in the healthcare sector, is garnering significant attention from investors due to its substantial upside potential and strategic positioning in..

COMPASS Pathways Plc (CMPS) Stock Analysis: Exploring a Promising 128% Upside Potential

COMPASS Pathways Plc (NASDAQ: CMPS) has been capturing investor attention with its pioneering approach in the mental health sector. Based in London, the company is making..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: 47.87% Potential Upside in the Biotech Arena

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is catching the attention of investors with its promising potential upside of 47.87%, despite its current challenges. As a clinical-stage biotechnology..

Inventiva S.A. (IVA) Stock Analysis: Unpacking the 190% Upside Potential in Biotech’s Bold Bet

Inventiva S.A. (IVA), a French biopharmaceutical innovator, presents a compelling investment opportunity within the healthcare sector, specifically in the biotechnology industry. Known for its development of..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Strong Revenue Growth and Strategic Collaborations Point to Promising Future

Investors with a keen eye on the biotechnology sector might find Theravance Biopharma, Inc. (NASDAQ: TBPH) an intriguing prospect. As a company focused on developing and..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a Potential 77% Upside in the Biotech Sector

Taysha Gene Therapies, Inc. (NASDAQ: TSHA), a pioneering company in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 77.77%. As a..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 77% Potential Upside Amidst Market Challenges

Tilray Brands, Inc. (NASDAQ: TLRY), a major player in the healthcare sector, specifically in the drug manufacturing industry, is navigating a complex landscape with its diversified..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating the Healthcare Sector with a -13.37% Potential Downside

InnovAge Holding Corp. (NASDAQ: INNV), a healthcare company specializing in senior care services, presents a fascinating case for investors navigating the medical care facilities industry. With..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Unveiling a Remarkable 189.87% Potential Upside

Investors looking for opportunities in the biotechnology sector may find Tectonic Therapeutic, Inc. (NASDAQ: TECX) particularly compelling. Despite the current market volatility, Tectonic’s focus on innovative..

Neuropace, Inc. (NPCE) Stock Analysis: A Healthcare Innovator with 23.9% Revenue Growth and Strong Buy Ratings

Neuropace, Inc. (NASDAQ: NPCE), a trailblazer in the medical devices sector, is capturing investor attention with its impressive 23.9% revenue growth and unanimous buy ratings from..

Ardelyx, Inc. (ARDX) Investor Outlook: Analyzing the 134% Potential Upside

Ardelyx, Inc. (NASDAQ: ARDX) stands out as a compelling opportunity in the biotechnology sector, capturing investor attention with a remarkable potential upside of 134%. This potential..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring a Potential 47.82% Upside in Biotechnology

Investors eyeing the biotechnology sector may find Arvinas, Inc. (ARVN) an intriguing prospect, particularly given the potential upside of nearly 48% as reflected by the current..

Pharvaris N.V. (PHVS) Stock Analysis: Potential 57.86% Upside Amid Biotech Innovations

Pharvaris N.V. (PHVS), a biopharmaceutical company rooted in Switzerland’s burgeoning biotech sector, is drawing attention from investors due to its promising pipeline of therapies targeting rare..

Avanos Medical, Inc. (AVNS) Stock Analysis: Exploring Growth Potential in the Medical Devices Sector

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector, has garnered attention for its innovative medical device solutions, particularly in the fields of..

Syndax Pharmaceuticals (SNDX): Analyst Ratings Suggest a 92% Upside Potential

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is a dynamic player in the biotechnology sector, with a focus on developing innovative cancer therapies. As a commercial-stage biopharmaceutical company,..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a Potential 161% Upside

Definitive Healthcare Corp. (NASDAQ: DH) is capturing investor attention with its potential for a significant upswing. Known for its innovative SaaS healthcare commercial intelligence platform, the..

Sana Biotechnology (SANA) Investor Outlook: A 144.90% Upside Potential in Innovative Cell Therapy

Sana Biotechnology, Inc. (NASDAQ: SANA), a dynamic player in the biotechnology sector, is drawing significant attention from investors with its innovative approach to using engineered cells..

Castle Biosciences, Inc. (CSTL) Stock Analysis: A Promising 145.58% Upside Potential

Castle Biosciences, Inc. (NASDAQ: CSTL) stands out in the healthcare sector, specifically within the diagnostics and research industry, as a company with a promising trajectory despite..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds